Why we are different. Onava is an AI drug discovery platform building the next generation of bispecific antibody discovery. We design and operate proprietary wet-lab assay platforms that generate large-scale, biologically meaningful data, and we use that data to train AI models that improve with every experiment we run.
The drug discovery industry generates enormous amounts of experimental data and throws most of it away. Each program runs in isolation, each experiment is treated as a one-time event, and the insights from failed candidates rarely inform what comes next.
Onava is built differently. Our platform compounds in value with every program we execute — a cross-program data flywheel that means the tenth candidate we optimize benefits from everything learned in the first nine. That structural advantage becomes more pronounced as we scale.
